Last update 23 Jan 2025

Ishin Pharmaceutical Co. Ltd.

Private Company

Overview

Related

2
Drugs associated with Ishin Pharmaceutical Co. Ltd.
ALLO-ASC-DFU(Anterogen)
Target-
Mechanism
Cell replacements
Active Org.
Anterogen Co., Ltd.Anterogen Co., Ltd.
Originator Org.
Anterogen Co., Ltd.Anterogen Co., Ltd.
Active Indication
Diabetic foot ulcer [+1]
Inactive Indication
Burns [+1]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
Nivadstrocel
Target-
Mechanism
Cell replacements
Active Org.-
Originator Org.
Ishin Pharmaceutical Co. Ltd.
Active Indication-
Inactive Indication
Epidermolysis Bullosa
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Ishin Pharmaceutical Co. Ltd.
JPRN-UMIN000028366
/ CompletedPhase 1/2
A clinical study to evaluate efficacy, safety and tolerability of ISN001 in dystrophic epidermolysis bullosa patients. - A clinical study to evaluate efficacy, safety and tolerability of ISN001 in dystrophic epidermolysis bullosa patients.
100 Clinical Results associated with Ishin Pharmaceutical Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Ishin Pharmaceutical Co. Ltd.
Login to view more data
100 Deals associated with Ishin Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Ishin Pharmaceutical Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ALLO-ASC-DFU(Anterogen)
Epidermolysis Bullosa
More
Pending
Nivadstrocel
Epidermolysis Bullosa
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free